|
⚲
|
| Keyboard |
| Kempharm Inc | |
|---|---|
| Ticker | ZVRA |
| CIK # | 0001434647 |
| CUSIP | 488445206 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 2656 Crosspark Road, Suite 100, Coralville, IA 52241 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Kempharm Inc | 2021-06-22 | 39.1 M | Exemption: 506(b) · Duration: One year or less · Commission: $2,345,912 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001434647] | 10-K | |
| [0001434647] | 10-Q | |
| [0001434647] | 3 | |
| [0001434647] | 4 | |
| [0001434647] | 8-K | |
| [0001434647] | D | |
| [0001434647] | SC 13D | |
| [0001434647] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bode John B
Stock Option (right to buy) · derivative
|
2026-03-24 | Option exercise | 39,200 | $0.00 | |
|
Bode John B
Stock Option (right to buy) · derivative
|
2026-03-24 | Option exercise | 39,200 | $0.00 | |
|
Bode John B
Common Stock
|
2026-03-24 | Option exercise | 39,200 | $4.97 | 194,824 |
|
Bode John B
Common Stock
|
2026-03-24 | Option exercise | 39,200 | $4.89 | 191,688 |
|
Renz Justin A
Stock Option (right to buy) · derivative
|
2026-03-18 | Grant | 300,000 | $0.00 | |
|
McFarlane Neil F
Common Stock
|
2026-02-09 | Sell | 14,625 | $8.56 | 125,190 |
|
McFarlane Neil F
Common Stock
|
2026-02-07 | Option exercise | 37,500 | ||
|
McFarlane Neil F
Restricted Stock Unit · derivative
|
2026-02-07 | Option exercise | 37,500 | $0.00 | |
|
Sangiovanni Timothy J
Common Stock
|
2026-02-03 | Sell | 3,000 | $9.18 | 27,540 |
|
Schafer Joshua
Common Stock
|
2026-02-03 | Sell | 10,500 | $9.19 | 96,495 |
|
McFarlane Neil F
Common Stock
|
2026-02-02 | Sell | 91,000 | $9.38 | 853,580 |
|
Sangiovanni Timothy J
Common Stock
|
2026-01-31 | Option exercise | 11,666 | ||
|
Schafer Joshua
Common Stock
|
2026-01-31 | Option exercise | 35,334 | ||
|
Schafer Joshua
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 35,334 | $0.00 | |
|
McFarlane Neil F
Common Stock
|
2026-01-31 | Option exercise | 233,334 | ||
|
McFarlane Neil F
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 233,334 | $0.00 | |
|
Sangiovanni Timothy J
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 11,666 | $0.00 | |
|
Thompson Rahsaan
Restricted Stock Unit · derivative
|
2026-01-30 | Option exercise | 11,333 | $0.00 | |
|
Schafer Joshua
Common Stock
|
2026-01-30 | Sell | 3,375 | $8.83 | 29,801 |
|
Quartel Adrian W
Common Stock
|
2026-01-30 | Option exercise | 11,333 | ||
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 148 | 44,609,810 |
| 2025-12-31 | 159 | 41,214,303 |
| 2025-09-30 | 166 | 43,565,944 |
| 2025-06-30 | 122 | 37,291,039 |
| 2025-03-31 | 113 | 36,274,988 |
| 2024-12-31 | 112 | 34,233,885 |
| 2024-09-30 | 109 | 29,811,152 |
| 2024-06-30 | 94 | 18,620,246 |
| 2024-03-31 | 90 | 14,166,254 |
| 2023-12-31 | 86 | 15,458,650 |
| 2023-09-30 | 79 | 11,070,975 |
| 2023-06-30 | 72 | 8,690,256 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Swedbank AB | [2026-06-30] | DFND | 439,410 | 439,410 |
| Hennion & Walsh Asset Management Inc | [2026-06-30] | SOLE | 383,706 | 383,706 |
| Simplify Asset Management Inc | [2026-06-30] | SOLE | 70,759 | 70,759 |
| City State Bank | [2026-06-30] | SOLE | 13,798 | 13,798 |
| Activest Wealth Management | [2026-06-30] | SOLE | 0 | 1,815 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 445 | 445 |
| Gamma Investing LLC | [2026-06-30] | DFND | 298 | 298 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 228 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 108 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 36 | 36 |
| JFS Wealth Advisors LLC | [2026-06-30] | SOLE | 0 | 2 | Prev | Page 1 | Next |